<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cardiovasc. Med.</journal-id>
<journal-title>Frontiers in Cardiovascular Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cardiovasc. Med.</abbrev-journal-title>
<issn pub-type="epub">2297-055X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcvm.2024.1363336</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cardiovascular Medicine</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Automated titanium fastener vs. hand-tied knots for prosthesis fixation in infective endocarditis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Kahrovic</surname><given-names>Amila</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/2135102/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib>
<contrib contrib-type="author"><name><surname>Angleitner</surname><given-names>Philipp</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1676324/overview" /><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib>
<contrib contrib-type="author"><name><surname>Herkner</surname><given-names>Harald</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1227661/overview" /><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Werner</surname><given-names>Paul</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1659755/overview" /><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib>
<contrib contrib-type="author"><name><surname>Poschner</surname><given-names>Thomas</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib>
<contrib contrib-type="author"><name><surname>Alajbegovic</surname><given-names>Leila</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib>
<contrib contrib-type="author"><name><surname>Kocher</surname><given-names>Alfred</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Ehrlich</surname><given-names>Marek</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1884795/overview" /><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Laufer</surname><given-names>G&#x00FC;nther</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1913698/overview" /></contrib>
<contrib contrib-type="author"><name><surname>Andreas</surname><given-names>Martin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1314186/overview" /><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>Department of Cardiac Surgery, Medical University of Vienna</institution>, <addr-line>Vienna</addr-line>, <country>Austria</country></aff>
<aff id="aff2"><label><sup>2</sup></label><institution>Department of Emergency Medicine, Medical University of Vienna</institution>, <addr-line>Vienna</addr-line>, <country>Austria</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Massimo Bonacchi, University of Florence, Italy</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Praveen Varma, Amrita Vishwa Vidyapeetham University, India</p>
<p>Philemon Gukop, St George&#x0027;s University Hospitals NHS Foundation Trust, United Kingdom</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Amila Kahrovic <email>amila.kahrovic@meduniwien.ac.at</email></corresp>
<fn fn-type="other" id="fn001"><p><bold>Abbreviations</bold> CABG, coronary artery bypass grafting; CI, confidence interval; CPB, cardiopulmonary bypass; ECMO, extracorporeal membrane oxygenation; EuroSCORE II, European System for Cardiac Operative Risk Evaluation II; HR, hazard ratio; IE, infective endocarditis.</p></fn>
</author-notes>
<pub-date pub-type="epub"><day>23</day><month>01</month><year>2024</year></pub-date>
<pub-date pub-type="collection"><year>2024</year></pub-date>
<volume>11</volume><elocation-id>1363336</elocation-id>
<history>
<date date-type="received"><day>30</day><month>12</month><year>2023</year></date>
<date date-type="accepted"><day>08</day><month>01</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2024 Kahrovic, Angleitner, Herkner, Werner, Poschner, Alajbegovic, Kocher, Ehrlich, Laufer and Andreas.</copyright-statement>
<copyright-year>2024</copyright-year><copyright-holder>Kahrovic, Angleitner, Herkner, Werner, Poschner, Alajbegovic, Kocher, Ehrlich, Laufer and Andreas</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<sec><title>Objectives</title>
<p>To date, there is no evidence regarding the safety of automated titanium fastener compared with hand-tied knots for prosthesis fixation in infective endocarditis.</p>
</sec>
<sec><title>Methods</title>
<p>Between January 2016 and December 2022, a total of 220 patients requiring surgery for infective endocarditis were included in this retrospective analysis. The primary study endpoint was re-endocarditis during follow-up. The secondary study endpoints included stroke onset, all-cause mortality, and a composite outcome of either re-endocarditis, stroke, or all-cause mortality during follow-up.</p>
</sec>
<sec><title>Results</title>
<p>Suture-securing with an automated titanium fastener was performed in 114 (51.8&#x0025;) patients, whereas the conventional technique of hand knot-tying was used in 106 (48.2&#x0025;) patients. The risk of re-endocarditis was significantly lower in the automated titanium fastener group, as shown in a multivariable proportional competing risk regression model (adjusted sub-hazard ratio 0.33, 95&#x0025; confidence interval 0.11&#x2013;0.99, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.048). The multivariable Cox proportional hazards regression analysis showed that the automated titanium fastener group was not associated with an increased risk of stroke-onset or attaining the composite outcome, respectively, (adjusted hazard ratio 0.54, 95&#x0025; confidence interval 0.27&#x2013;1.08, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.082), (adjusted hazard ratio 0.65, 95&#x0025; confidence interval 0.42&#x2013;1.02, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.061). Also, this group was not associated with an increased risk of all-cause mortality, as demonstrated in the multivariable Poisson regression analysis (adjusted incidence-rate ratio 1.42, 95&#x0025; confidence interval 0.83&#x2013;2.42, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.202).</p>
</sec>
<sec><title>Conclusions</title>
<p>The use of automated titanium fastener device seems to be safe for infective endocarditis. Analyses of larger cohorts are required.</p>
</sec>
</abstract>
<kwd-group>
<kwd>infective endocarditis</kwd>
<kwd>automated titanium fastener</kwd>
<kwd>hand-tied knots</kwd>
<kwd>suture-securing techniques</kwd>
<kwd>prosthesis fixation</kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="7"/><equation-count count="0"/><ref-count count="18"/><page-count count="0"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Heart Surgery</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro"><title>Introduction</title>
<p>Numerous surgical methods are established for the treatment of active infective endocarditis (IE), including valve replacement with a biological or mechanical prosthesis. For prosthesis fixation, sutures can be secured by either automated titanium fastener (Cor-Knot Device, LSI Solutions, Victor, New York, United States) or conventional hand-tied knots (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>). The automated titanium fastener device enables suture securing with a tiny titanium cylinder. At the suture closure site, the automated titanium fastener is deployed in crimped form, creating a firm suture contact with a single-hand squeeze (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>).</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>Suture-securing techniques for prosthesis fixation in active IE: (<bold>A</bold>) automated titanium fastener; (<bold>B</bold>) hand-tied knots.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-11-1363336-g001.tif"/>
</fig>
<p>Currently, there is no evidence regarding the safety of the automated titanium fastener device in comparison to the hand-tied knots for IE. Indeed, current guidelines do not provide recommendations for the superiority of any suture-securing technique (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>).</p>
<p>This study aims to compare clinical outcomes among study groups, based on the suture-securing technique used (automated titanium fastener group vs. hand-tied knots group) for prosthesis fixation in active IE.</p>
</sec>
<sec id="s2" sec-type="methods"><title>Materials and methods</title>
<sec id="s2a"><title>Ethical statement</title>
<p>This study was reviewed and approved by the Ethics Committee of the Medical University of Vienna (Ethical Number: 1872/2022; approval date 16.01.2023). The individual patient&#x0027;s consent was waived.</p>
</sec>
<sec id="s2b"><title>Patients and clinical data</title>
<p>Patients were screened using the institutional database of the Department of Cardiac Surgery at the Medical University of Vienna. Between January 2016 and December 2022, 220 consecutive patients requiring surgery for active IE were included in this retrospective study. Diagnosis of IE was based on the modified Duke criteria and current guidelines (<xref ref-type="bibr" rid="B3">3</xref>&#x2013;<xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>All patients underwent surgical valve replacement with either biological or mechanical prosthesis at the aortic or/and mitral position. The exclusion criteria were age&#x2009;&#x003C;&#x2009;18 years, aortic root replacement, homograft implantation, isolated mitral valve repair, and a combination of both suture-securing techniques.</p>
<p>The operations were performed by multiple senior surgeons. For all prostheses, the valve stitch placement technique involved the utilization of U-stitches with pledgets. The surgical treatment of IE at our institution is in line with current guidelines including radical debridement of all infected and necrotic tissue, followed by the reconstruction of any remaining defects (<xref ref-type="bibr" rid="B3">3</xref>). Additionally, during the surgery for IE all remaining tissue and surgical pledgets were soaked in an intraoperative disinfectant (povidone-iodine), which is standard practice at our department.</p>
<p>The patients were grouped based on the suture-securing technique used for prosthesis fixation (automated titanium fastener group vs. hand-tied knots group). Operation reports and institutional surgery protocols were reviewed to identify the suture-securing technique. The decision towards using either of the suture-securing techniques was based primarily on the surgeon&#x0027;s personal preference. The use of an automated titanium fastener device started in the year 2016 at our department.</p>
</sec>
<sec id="s2c"><title>Study endpoints</title>
<p>The primary study endpoint was re-endocarditis during follow-up. The secondary study endpoints included stroke onset, all-cause mortality, and a composite outcome during follow-up. The composite outcome was defined as an occurrence of either re-endocarditis, stroke, or all-cause mortality during follow-up. A stroke was defined as an acute neurological deficit with evidence of a new lesion on a neuroimaging scan (<xref ref-type="bibr" rid="B6">6</xref>). The patient was considered to have had a stroke when either ischemic or hemorrhagic stroke was diagnosed. The study endpoints were identified from patients&#x0027; medical records. Mortality data were obtained from the Austrian statistics department. No patient was lost to follow-up. A comprehensive dataset was generated through the prospectively maintained database at our department. The last date of follow-up was set for January 5, 2023. The median follow-up time was 664 days for the automated titanium fastener group and 900 days for the hand-tied knots group (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.217).</p>
</sec>
<sec id="s2d"><title>Statistical analysis</title>
<p>Continuous variables are presented as median and 1st and 3rd quartile, and categorical variables as count and percentages. The Mann&#x2013;Whitney <italic>U</italic> test was applied to analyze continuous variables with non-normal distributions. For the comparison of categorical variables, the chi-square test was used.</p>
<p>To estimate the effect of the suture-securing technique (automated titanium fastener group vs. hand-tied knots group) on the primary as well as secondary study endpoints, univariable and multivariable proportional hazards regression analyses were performed with the exposure time starting at the date of surgery. Based on directed acyclic graph using current published evidence and clinical experience we selected co-variables to be included in the multivariable models.</p>
<p>The analysis of the primary study endpoint (re-endocarditis) was performed using a multivariable proportional subhazards Fine and Gray regression model accounting for death as a competing event. The primary study endpoint was depicted by the Kaplan&#x2013;Meier cumulative event curves of both study groups.</p>
<p>The secondary study endpoints: stroke and composite outcome were analyzed using multivariable Cox proportional hazards regression models. The effects were quantified as hazard ratio (HR) with 95&#x0025; confidence interval (CI). The Kaplan&#x2013;Meier cumulative event curves for the composite outcome were visualized for both study groups. For the secondary study endpoint, all-cause mortality, the multivariable Poisson regression model was used. The effects were calculated as an incidence-rate ratio with 95&#x0025; CI.</p>
<p>We used the likelihood ratio test to assess deviations from linearity and to test for interactions.</p>
<p>For superiority, a two-sided <italic>p</italic>-value of less than 0.05 was considered to indicate statistical significance. SPSS 27.0 (IBM Corp, Armonk, NY, USA) and STATA 16.1 software (StataCorp LLC, College Station, TX, USA) were used for statistical analysis.</p>
</sec>
</sec>
<sec id="s3" sec-type="results"><title>Results</title>
<sec id="s3a"><title>Baseline characteristics</title>
<p>Suture-securing with an automated titanium fastener was performed in 114 (51.8&#x0025;) patients, whereas the conventional technique of hand knot-tying was used in 106 (48.2&#x0025;) patients (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>). The automated titanium fastener group had a significantly higher rate of preoperative atrial fibrillation (40.4&#x0025; vs. 27.4&#x0025;; <italic>p</italic>&#x2009;&#x003D;&#x2009;0.042) and diabetes mellitus (27.2&#x0025; vs. 16.0&#x0025;; <italic>p</italic>&#x2009;&#x003D;&#x2009;0.045). All other baseline characteristics were comparable between groups.</p>
<table-wrap id="T1" position="float"><label>Table 1</label>
<caption><p>Baseline characteristics.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Variables</th>
<th valign="top" align="center">Automated titanium fastener<break/><italic>N</italic>&#x2009;&#x003D;&#x2009;114<break/>(51.8&#x0025;)</th>
<th valign="top" align="center">Hand-tied knots<break/><italic>N</italic>&#x2009;&#x003D;&#x2009;106<break/>(48.2&#x0025;)</th>
<th valign="top" align="center"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age (years) (25th&#x2013;75th interval)</td>
<td valign="top" align="center">63.4 (52.2&#x2013;72.5)</td>
<td valign="top" align="center">61.1 (47.1&#x2013;69.1)</td>
<td valign="top" align="center">0.117</td>
</tr>
<tr>
<td valign="top" align="left">Female (&#x0025;)</td>
<td valign="top" align="center">32 (28.1)</td>
<td valign="top" align="center">30 (28.3)</td>
<td valign="top" align="center">0.970</td>
</tr>
<tr>
<td valign="top" align="left">EuroSCORE II (25th&#x2013;75th interval)</td>
<td valign="top" align="center">11.5 (5.2&#x2013;23.0)</td>
<td valign="top" align="center">11.3 (5.5&#x2013;30.3)</td>
<td valign="top" align="center">0.908</td>
</tr>
<tr>
<td valign="top" align="left">Left ventricular function &#x2265;50&#x0025; (&#x0025;)</td>
<td valign="top" align="center">87 (76.3)</td>
<td valign="top" align="center">86 (81.1)</td>
<td valign="top" align="center">0.383</td>
</tr>
<tr>
<td valign="top" align="left">Hypertension (&#x0025;)</td>
<td valign="top" align="center">77 (67.5)</td>
<td valign="top" align="center">63 (59.4)</td>
<td valign="top" align="center">0.211</td>
</tr>
<tr>
<td valign="top" align="left">Atrial fibrillation (&#x0025;)</td>
<td valign="top" align="center">46 (40.4)</td>
<td valign="top" align="center">29 (27.4)</td>
<td valign="top" align="center"><bold>0</bold><bold>.</bold><bold>042</bold></td>
</tr>
<tr>
<td valign="top" align="left">Preoperative stroke (within 30 days) (&#x0025;)</td>
<td valign="top" align="center">20 (17.5)</td>
<td valign="top" align="center">26 (24.5)</td>
<td valign="top" align="center">0.203</td>
</tr>
<tr>
<td valign="top" align="left">Diabetes mellitus (&#x0025;)</td>
<td valign="top" align="center">31 (27.2)</td>
<td valign="top" align="center">17 (16.0)</td>
<td valign="top" align="center"><bold>0</bold>.<bold>045</bold></td>
</tr>
<tr>
<td valign="top" align="left">Dialysis (&#x0025;)</td>
<td valign="top" align="center">16 (14.0)</td>
<td valign="top" align="center">14 (13.2)</td>
<td valign="top" align="center">0.858</td>
</tr>
<tr>
<td valign="top" align="left">Prosthetic valve endocarditis (&#x0025;)</td>
<td valign="top" align="center">34 (29.8)</td>
<td valign="top" align="center">29 (27.4)</td>
<td valign="top" align="center">0.686</td>
</tr>
<tr>
<td valign="top" align="left">Positive blood culture prior to surgery (&#x0025;)</td>
<td valign="top" align="center">28 (24.6)</td>
<td valign="top" align="center">35 (33.0)</td>
<td valign="top" align="center">0.166</td>
</tr>
<tr>
<td valign="top" align="left">Negative blood culture after initial evidence of bacteriemia (&#x0025;)</td>
<td valign="top" align="center">60 (52.6)</td>
<td valign="top" align="center">59 (55.7)</td>
<td valign="top" align="center">0.652</td>
</tr>
<tr>
<td valign="top" align="left" colspan="4">Positive echocardiography findings</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Vegetation (&#x0025;)</td>
<td valign="top" align="center">97 (85.1)</td>
<td valign="top" align="center">92 (86.8)</td>
<td valign="top" align="center">0.717</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Annular abscess (&#x0025;)</td>
<td valign="top" align="center">48 (42.1)</td>
<td valign="top" align="center">38 (35.8)</td>
<td valign="top" align="center">0.342</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Pseudoaneurysm (&#x0025;)</td>
<td valign="top" align="center">6 (5.3)</td>
<td valign="top" align="center">4 (3.8)</td>
<td valign="top" align="center">0.596</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Fistula (&#x0025;)</td>
<td valign="top" align="center">2 (1.8)</td>
<td valign="top" align="center">6 (5.7)</td>
<td valign="top" align="center">0.122</td>
</tr>
<tr>
<td valign="top" align="left">Peripheral embolism (&#x0025;)</td>
<td valign="top" align="center">63 (55.3)</td>
<td valign="top" align="center">58 (54.7)</td>
<td valign="top" align="center">0.935</td>
</tr>
<tr>
<td valign="top" align="left">Intravenous drug abuse (&#x0025;)</td>
<td valign="top" align="center">11 (9.6)</td>
<td valign="top" align="center">10 (9.4)</td>
<td valign="top" align="center">0.957</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1"><p>Bold indicates statistical significance (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05).</p></fn>
<fn id="table-fn2"><p>Values are presented as <italic>n</italic> (&#x0025;) or median (interquartile range).</p></fn>
<fn id="table-fn3"><p>Categorical variables were compared using chi-square test, and continuous variables using Mann&#x2013;Whitney <italic>U</italic> test.</p></fn>
<fn id="table-fn4"><p>EuroSCORE II: European System for Cardiac Operative Risk Evaluation II.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3b"><title>Blood culture results</title>
<p><xref ref-type="table" rid="T2">Table&#x00A0;2</xref> lists species that were identified through blood culture before surgery. The rate of detected species was similar between study groups.</p>
<table-wrap id="T2" position="float"><label>Table 2</label>
<caption><p>Blood culture results.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Variables</th>
<th valign="top" align="center">Automated titanium fastener<break/><italic>N</italic>&#x2009;&#x003D;&#x2009;114<break/>(51.8&#x0025;)</th>
<th valign="top" align="center">Hand-tied knots<break/><italic>N</italic>&#x2009;&#x003D;&#x2009;106<break/>(48.2&#x0025;)</th>
<th valign="top" align="center"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Staphylococcus aureus (&#x0025;)</td>
<td valign="top" align="center">22 (19.3)</td>
<td valign="top" align="center">23 (21.7)</td>
<td valign="top" align="center">0.659</td>
</tr>
<tr>
<td valign="top" align="left">Methicillin-resistant Staphylococcus aureus (&#x0025;)</td>
<td valign="top" align="center">0 (0.0)</td>
<td valign="top" align="center">2 (1.9)</td>
<td valign="top" align="center">0.141</td>
</tr>
<tr>
<td valign="top" align="left">Viridans group streptococci (&#x0025;)</td>
<td valign="top" align="center">20 (17.5)</td>
<td valign="top" align="center">15 (14.2)</td>
<td valign="top" align="center">0.492</td>
</tr>
<tr>
<td valign="top" align="left">Coagulase-negative staphylococci (&#x0025;)</td>
<td valign="top" align="center">12 (10.5)</td>
<td valign="top" align="center">12 (11.3)</td>
<td valign="top" align="center">0.850</td>
</tr>
<tr>
<td valign="top" align="left">Enterococcus species (&#x0025;)</td>
<td valign="top" align="center">8 (7.0)</td>
<td valign="top" align="center">13 (12.3)</td>
<td valign="top" align="center">0.186</td>
</tr>
<tr>
<td valign="top" align="left">Group B Streptococci (&#x0025;)</td>
<td valign="top" align="center">2 (1.8)</td>
<td valign="top" align="center">2 (1.9)</td>
<td valign="top" align="center">0.941</td>
</tr>
<tr>
<td valign="top" align="left">Enterobacteriaceae (&#x0025;)</td>
<td valign="top" align="center">1 (0.9)</td>
<td valign="top" align="center">3 (2.8)</td>
<td valign="top" align="center">0.279</td>
</tr>
<tr>
<td valign="top" align="left">Propionibacterium acnes (&#x0025;)</td>
<td valign="top" align="center">1 (0.9)</td>
<td valign="top" align="center">2 (1.9)</td>
<td valign="top" align="center">0.519</td>
</tr>
<tr>
<td valign="top" align="left">Streptococcus bovis (&#x0025;)</td>
<td valign="top" align="center">1 (0.9)</td>
<td valign="top" align="center">1 (0.9)</td>
<td valign="top" align="center">0.959</td>
</tr>
<tr>
<td valign="top" align="left">Other (<italic>N</italic>&#x2009;&#x003D;&#x2009;1 each) (&#x0025;)</td>
<td valign="top" align="center">6 (5.3)</td>
<td valign="top" align="center">10 (9.4)</td>
<td valign="top" align="center">0.234</td>
</tr>
<tr>
<td valign="top" align="left">Multiple species (&#x003E;1 species) (&#x0025;)</td>
<td valign="top" align="center">15 (13.2)</td>
<td valign="top" align="center">11 (10.4)</td>
<td valign="top" align="center">0.523</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6"><p>Values are presented as <italic>n</italic> (&#x0025;).</p></fn>
<fn id="table-fn7"><p>Categorical variables were compared using chi-square test.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3c"><title>Operative characteristics</title>
<p>The operative characteristics are summarized in <xref ref-type="table" rid="T3">Table&#x00A0;3</xref>. No differences in eras were observed among study groups. Aortic valve replacement, mitral valve replacement, as well as combined aortic and mitral valve replacement were performed at similar rates. For aortic valve replacement, the Medtronic Avalus prosthesis was implanted significantly more frequently in the automated titanium fastener group (12.3&#x0025; vs. 4.7&#x0025;; <italic>p</italic>&#x2009;&#x003D;&#x2009;0.046) (<xref ref-type="sec" rid="s11">Supplementary Table S1</xref>). The rate of annular patch augmentation, Commando procedure, ventricular septal defect closure, and aortic root enlargement was similar between groups (<xref ref-type="table" rid="T3">Table&#x00A0;3</xref>). Coronary artery bypass grafting (CABG) was performed with a significantly higher rate in the automated titanium fastener group (19.3&#x0025; vs. 9.4&#x0025;; <italic>p</italic>&#x2009;&#x003D;&#x2009;0.038). The cross-clamp times, as well as cardiopulmonary bypass (CPB) times, were comparable among groups.</p>
<table-wrap id="T3" position="float"><label>Table 3</label>
<caption><p>Operative characteristics.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Variables</th>
<th valign="top" align="center">Automated titanium fastener<break/><italic>N</italic>&#x2009;&#x003D;&#x2009;114<break/>(51.8&#x0025;)</th>
<th valign="top" align="center">Hand-tied knots<break/><italic>N</italic>&#x2009;&#x003D;&#x2009;106<break/>(48.2&#x0025;)</th>
<th valign="top" align="center"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Full sternotomy (&#x0025;)</td>
<td valign="top" align="center">111 (97.4)</td>
<td valign="top" align="center">102 (96.2)</td>
<td valign="top" align="center">0.630</td>
</tr>
<tr>
<td valign="top" align="left">Re-sternotomy (&#x0025;)</td>
<td valign="top" align="center">35 (30.7)</td>
<td valign="top" align="center">31 (29.2)</td>
<td valign="top" align="center">0.814</td>
</tr>
<tr>
<td valign="top" align="left">Era (&#x0025;)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.091</td>
</tr>
<tr>
<td valign="top" align="left">2016&#x2013;2019</td>
<td valign="top" align="center">57 (46.7)</td>
<td valign="top" align="center">65 (53.3)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">2020&#x2013;2022</td>
<td valign="top" align="center">57 (58.2)</td>
<td valign="top" align="center">41 (41.8)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Aortic valve replacement (&#x0025;)</td>
<td valign="top" align="center">59 (51.8)</td>
<td valign="top" align="center">55 (51.9)</td>
<td valign="top" align="center">0.984</td>
</tr>
<tr>
<td valign="top" align="left">Mitral valve replacement (&#x0025;)</td>
<td valign="top" align="center">36 (31.6)</td>
<td valign="top" align="center">30 (28.3)</td>
<td valign="top" align="center">0.596</td>
</tr>
<tr>
<td valign="top" align="left">Combined aortic and mitral valve replacement (&#x0025;)</td>
<td valign="top" align="center">19 (16.7)</td>
<td valign="top" align="center">21 (19.8)</td>
<td valign="top" align="center">0.546</td>
</tr>
<tr>
<td valign="top" align="left">Right side involvement</td>
<td valign="top" align="center">18 (15.8)</td>
<td valign="top" align="center">9 (8.5)</td>
<td valign="top" align="center">0.099</td>
</tr>
<tr>
<td valign="top" align="left">Annular patch augmentation (&#x0025;)</td>
<td valign="top" align="center">26 (22.8)</td>
<td valign="top" align="center">29 (27.4)</td>
<td valign="top" align="center">0.436</td>
</tr>
<tr>
<td valign="top" align="left">Commando procedure (&#x0025;)</td>
<td valign="top" align="center">3 (2.6)</td>
<td valign="top" align="center">3 (2.8)</td>
<td valign="top" align="center">0.928</td>
</tr>
<tr>
<td valign="top" align="left">Ventricular septal defect closure (&#x0025;)</td>
<td valign="top" align="center">1 (0.9)</td>
<td valign="top" align="center">2 (1.9)</td>
<td valign="top" align="center">0.519</td>
</tr>
<tr>
<td valign="top" align="left">Aortic root enlargement (&#x0025;)</td>
<td valign="top" align="center">7 (6.1)</td>
<td valign="top" align="center">9 (8.5)</td>
<td valign="top" align="center">0.502</td>
</tr>
<tr>
<td valign="top" align="left">CABG (&#x0025;)</td>
<td valign="top" align="center">22 (19.3)</td>
<td valign="top" align="center">10 (9.4)</td>
<td valign="top" align="center"><bold>0</bold><bold>.</bold><bold>038</bold></td>
</tr>
<tr>
<td valign="top" align="left">CPB time (min) (25th&#x2013;75th interval)</td>
<td valign="top" align="center">144 (106&#x2013;192)</td>
<td valign="top" align="center">145 (105&#x2013;206)</td>
<td valign="top" align="center">0.487</td>
</tr>
<tr>
<td valign="top" align="left">Cross clamp time (min) (25th&#x2013;75th interval)</td>
<td valign="top" align="center">104 (72&#x2013;136)</td>
<td valign="top" align="center">100 (74&#x2013;137)</td>
<td valign="top" align="center">0.665</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn8"><p>Bold indicates statistical significance (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05).</p></fn>
<fn id="table-fn9"><p>Values are presented as <italic>n</italic> (&#x0025;) or median (interquartile range). Categorical variables were compared using chi-square test, and continuous variables using Mann&#x2013;Whitney <italic>U</italic> test.</p></fn>
<fn id="table-fn10"><p>CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3d"><title>Primary study endpoint</title>
<p>During the follow-up period, 18 patients (8.2&#x0025;) reached the primary study endpoint. Univariable Cox proportional hazards regression analysis (<xref ref-type="table" rid="T4">Table&#x00A0;4</xref>) demonstrated a significantly lower risk of re-endocarditis in the automated titanium fastener group (HR 0.35, 95&#x0025; CI 0.12&#x2013;0.96, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.042). A multivariable proportional competing risk regression analysis showed that suture-securing with an automated titanium fastener was independently associated with a significantly lower risk of re-endocarditis during follow-up (adjusted sub-hazard ratio 0.33, 95&#x0025; CI 0.11&#x2013;0.99, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.048) (<xref ref-type="table" rid="T4">Table&#x00A0;4</xref>; <xref ref-type="sec" rid="s11">Supplementary Table S</xref><xref ref-type="table" rid="T2">2</xref>). The median time to re-endocarditis was significantly longer in the automated titanium fastener group (271 days vs. 58 days <italic>p</italic>&#x2009;&#x003D;&#x2009;0.040). The Kaplan&#x2013;Meier cumulative event curves of both study groups are depicted in <xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>.</p>
<table-wrap id="T4" position="float"><label>Table 4</label>
<caption><p>Study endpoints.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" rowspan="2">&#x00A0;</th>
<th valign="top" align="center">Automated titanium fastener<break/><italic>N</italic>&#x2009;&#x003D;&#x2009;114<break/>(51.8&#x0025;)</th>
<th valign="top" align="center">Hand-tied knots<break/><italic>N</italic>&#x2009;&#x003D;&#x2009;106<break/>(48.2&#x0025;)</th>
<th valign="top" align="center" colspan="2">Univariable relative effects</th>
<th valign="top" align="center" colspan="2">Multivariable relative effects</th>
</tr>
<tr>
<th valign="top" align="center"><italic>n</italic> (&#x0025;)</th>
<th valign="top" align="center"><italic>n</italic> (&#x0025;)</th>
<th valign="top" align="center">95&#x0025; CI</th>
<th valign="top" align="center"><italic>p</italic>-value</th>
<th valign="top" align="center">95&#x0025; CI</th>
<th valign="top" align="center"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Re-endocarditis<xref ref-type="table-fn" rid="table-fn13"><sup>a</sup></xref></td>
<td valign="top" align="center">5 (4.4)</td>
<td valign="top" align="center">13 (12.3)</td>
<td valign="top" align="center">0.35 (0.12&#x2013;0.96)</td>
<td valign="top" align="center"><bold>0</bold><bold>.</bold><bold>042</bold></td>
<td valign="top" align="center">0.33 (0.11&#x2013;0.99)</td>
<td valign="top" align="center"><bold>0</bold>.<bold>048</bold></td>
</tr>
<tr>
<td valign="top" align="left">Stroke<xref ref-type="table-fn" rid="table-fn14"><sup>b</sup></xref></td>
<td valign="top" align="center">13 (11.4)</td>
<td valign="top" align="center">23 (21.7)</td>
<td valign="top" align="center">0.52 (0.24&#x2013;1.03)</td>
<td valign="top" align="center">0.061</td>
<td valign="top" align="center">0.54 (0.27&#x2013;1.08)</td>
<td valign="top" align="center">0.082</td>
</tr>
<tr>
<td valign="top" align="left">All-cause mortality<xref ref-type="table-fn" rid="table-fn15"><sup>c</sup></xref></td>
<td valign="top" align="center">28 (24.6)</td>
<td valign="top" align="center">30 (28.3)</td>
<td valign="top" align="center">1.17 (0.70&#x2013;1.96)</td>
<td valign="top" align="center">0.547</td>
<td valign="top" align="center">1.42 (0.83&#x2013;2.42)</td>
<td valign="top" align="center">0.202</td>
</tr>
<tr>
<td valign="top" align="left">Composite outcome<xref ref-type="table-fn" rid="table-fn16"><sup>d</sup></xref></td>
<td valign="top" align="center">33 (29.0)</td>
<td valign="top" align="center">49 (46.2)</td>
<td valign="top" align="center">0.61 (0.39&#x2013;0.96)</td>
<td valign="top" align="center"><bold>0</bold>.<bold>031</bold></td>
<td valign="top" align="center">0.65 (0.42&#x2013;1.02)</td>
<td valign="top" align="center">0.061</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn11"><p>Bold indicates statistical significance (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05).</p></fn>
<fn id="table-fn12"><p>CI, confidence interval; HR, hazard ratio.</p></fn>
<fn id="table-fn13"><label><sup>a</sup></label><p>Effects calculated as sub-hazard ratio based on multivariable proportional competing risk regression model.</p></fn>
<fn id="table-fn14"><label><sup>b</sup></label><p>Effects calculated as HR based on multivariable Cox proportional hazards regression model.</p></fn>
<fn id="table-fn15"><label><sup>c</sup></label><p>Effects calculated as incidence-rate ratio based on multivariable Poisson regression model.</p></fn>
<fn id="table-fn16"><label><sup>d</sup></label><p>Effects calculated as HR based on multivariable Cox proportional hazards regression model.</p></fn>
</table-wrap-foot>
</table-wrap>
<fig id="F2" position="float"><label>Figure 2</label>
<caption><p>Kaplan-Meier cumulative event curves show the probability of re-endocarditis between the automated titanium fastener and hand-tied knots group. CI, confidence interval.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-11-1363336-g002.tif"/>
</fig>
</sec>
<sec id="s3e"><title>Secondary study endpoints</title>
<p>During the follow-up period, a stroke occurred in 36 patients (16.4&#x0025;). The automated titanium fastener was not associated with an increased risk of stroke, as shown in the multivariable Cox proportional hazards regression model (adjusted HR 0.54, 95&#x0025; CI 0.27&#x2013;1.08, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.082) (<xref ref-type="table" rid="T4">Table&#x00A0;4</xref>; <xref ref-type="sec" rid="s11">Supplementary Table S</xref><xref ref-type="table" rid="T3">3</xref>). Moreover, preoperative stroke (within 30 days) was independently associated with a significantly increased risk of stroke onset during the follow-up period (adjusted HR 2.14, 95&#x0025; CI 1.02&#x2013;4.45, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.043) (<xref ref-type="sec" rid="s11">Supplementary Table S</xref><xref ref-type="table" rid="T3">3</xref>).</p>
<p>Mortality occurred in 58 patients (26.4&#x0025;) during the follow-up period. As demonstrated in the multivariable Poisson regression analysis, the automated titanium fastener group was not associated with an increased risk of all-cause mortality (adjusted incidence-rate ratio 1.42, 95&#x0025; CI 0.83&#x2013;2.42, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.202) (<xref ref-type="table" rid="T4">Table&#x00A0;4</xref>; <xref ref-type="sec" rid="s11">Supplementary Table S</xref><xref ref-type="table" rid="T4">4</xref>).</p>
<p>A composite outcome (defined as occurrence of either re-endocarditis, stroke, or all-cause mortality) was reached in 82 (37.3&#x0025;) patients throughout the follow-up period. Univariable Cox proportional hazards regression analysis (<xref ref-type="table" rid="T4">Table&#x00A0;4</xref>) showed a significantly lower risk of experiencing the composite outcome in the automated titanium fastener group (HR 0.61, 95&#x0025; CI 0.39&#x2013;0.96, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.031). In the multivariable Cox proportional hazards regression model, the automated titanium fastener was not associated with an increased risk of attaining the composite outcome (adjusted HR 0.65, 95&#x0025; CI 0.42&#x2013;1.02, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.061) (<xref ref-type="table" rid="T4">Table&#x00A0;4</xref>; <xref ref-type="sec" rid="s11">Supplementary Table S5</xref>). The Kaplan&#x2013;Meier cumulative event curves were visualized for both study groups (<xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref>).</p>
<fig id="F3" position="float"><label>Figure 3</label>
<caption><p>Kaplan&#x2013;Meier cumulative event curves show the probability of attaining a composite outcome between the automated titanium fastener and hand-tied knots group. CI, confidence interval.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-11-1363336-g003.tif"/>
</fig>
</sec>
<sec id="s3f"><title>In-hospital postoperative adverse events and outcomes</title>
<p>The rates of in-hospital postoperative adverse events were similar between the study groups (<xref ref-type="table" rid="T5">Table&#x00A0;5</xref>). Regarding outcomes, the rate of non-IE-related reoperation was significantly lower in the automated titanium fastener group (0.0&#x0025; vs. 4.7&#x0025;; <italic>p</italic>&#x2009;&#x003D;&#x2009;0.019) (<xref ref-type="table" rid="T5">Table&#x00A0;5</xref>). The causes of non-IE-related reoperation in the hand-tied knots group were major paravalvular leak (2.7&#x0025;), aortic dissection (0.9&#x0025;), ascending aortic aneurysm (0.9&#x0025;), and ventricular aneurysm (0.9&#x0025;). Noteworthy, the rate of re-endocarditis with an initial pathogen was significantly lower in the automated titanium fastener group (1.8&#x0025; vs. 9.4&#x0025;, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.012).</p>
<table-wrap id="T5" position="float"><label>Table 5</label>
<caption><p>In-hospital postoperative adverse events and outcomes.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Variables</th>
<th valign="top" align="center">Automated titanium fastener<break/><italic>N</italic>&#x2009;&#x003D;&#x2009;114<break/>(51.8&#x0025;)</th>
<th valign="top" align="center">Hand-tied knots<break/><italic>N</italic>&#x2009;&#x003D;&#x2009;106<break/>(48.2&#x0025;)</th>
<th valign="top" align="center"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="4">In-hospital postoperative adverse events</td>
</tr>
<tr>
<td valign="top" align="left">Atrial fibrillation (&#x0025;)</td>
<td valign="top" align="center">37 (32.5)</td>
<td valign="top" align="center">36 (34.0)</td>
<td valign="top" align="center">0.813</td>
</tr>
<tr>
<td valign="top" align="left">Dialysis (&#x0025;)</td>
<td valign="top" align="center">21 (18.4)</td>
<td valign="top" align="center">17 (16.0)</td>
<td valign="top" align="center">0.640</td>
</tr>
<tr>
<td valign="top" align="left">ECMO support (&#x0025;)</td>
<td valign="top" align="center">14 (12.3)</td>
<td valign="top" align="center">18 (17.0)</td>
<td valign="top" align="center">0.323</td>
</tr>
<tr>
<td valign="top" align="left">Permanent pacemaker implantation (&#x0025;)</td>
<td valign="top" align="center">11 (9.6)</td>
<td valign="top" align="center">10 (9.4)</td>
<td valign="top" align="center">0.957</td>
</tr>
<tr>
<td valign="top" align="left">30-day mortality (&#x0025;)</td>
<td valign="top" align="center">6 (5.3)</td>
<td valign="top" align="center">8 (7.5)</td>
<td valign="top" align="center">0.488</td>
</tr>
<tr>
<td valign="top" align="left" colspan="4">Outcomes</td>
</tr>
<tr>
<td valign="top" align="left" colspan="4">Stroke</td>
</tr>
<tr>
<td valign="top" align="left">Ischemic (&#x0025;)</td>
<td valign="top" align="center">7 (6.1)</td>
<td valign="top" align="center">12 (11.3)</td>
<td valign="top" align="center">0.172</td>
</tr>
<tr>
<td valign="top" align="left">Hemorrhagic (&#x0025;)</td>
<td valign="top" align="center">1 (0.9)</td>
<td valign="top" align="center">5 (4.7)</td>
<td valign="top" align="center">0.081</td>
</tr>
<tr>
<td valign="top" align="left">Mixed lesion (&#x0025;)</td>
<td valign="top" align="center">5 (4.4)</td>
<td valign="top" align="center">6 (5.7)</td>
<td valign="top" align="center">0.665</td>
</tr>
<tr>
<td valign="top" align="left">Non-IE related reoperation (&#x0025;)</td>
<td valign="top" align="center">0 (0.0)</td>
<td valign="top" align="center">5 (4.7)</td>
<td valign="top" align="center"><bold>0</bold>.<bold>019</bold></td>
</tr>
<tr>
<td valign="top" align="left" colspan="4">Re-endocarditis (&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Initial pathogen</td>
<td valign="top" align="center">2 (1.8&#x0025;)</td>
<td valign="top" align="center">10 (9.4)</td>
<td valign="top" align="center"><bold>0</bold>.<bold>012</bold></td>
</tr>
<tr>
<td valign="top" align="left">New pathogen</td>
<td valign="top" align="center">3 (2.6&#x0025;)</td>
<td valign="top" align="center">3 (2.8&#x0025;)</td>
<td valign="top" align="center">0.928</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn17"><p>Bold indicates statistical significance (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05).</p></fn>
<fn id="table-fn18"><p>Values are presented as <italic>n</italic> (&#x0025;).</p></fn>
<fn id="table-fn19"><p>Categorical variables were compared using chi-square test.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3g"><title>Duration of antibiotic therapy and blood utilization</title>
<p>No significant difference was observed regarding duration of antibiotic therapy between automated titanium fastener group and hand-tied knots group (51 days, interquartile range 42&#x2013;66, vs. 58 days, interquartile range 43&#x2013;78; <italic>p</italic>&#x2009;&#x003D;&#x2009;0.053) (<xref ref-type="table" rid="T6">Table&#x00A0;6</xref>).</p>
<table-wrap id="T6" position="float"><label>Table 6</label>
<caption><p>Duration of antibiotic therapy and blood utilization.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Variables</th>
<th valign="top" align="center">Automated titanium fastener<break/><italic>N</italic>&#x2009;&#x003D;&#x2009;114<break/>(51.8&#x0025;)</th>
<th valign="top" align="center">Hand-tied knots<break/><italic>N</italic>&#x2009;&#x003D;&#x2009;106<break/>(48.2&#x0025;)</th>
<th valign="top" align="center"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="4">Duration of antibiotic therapy</td>
</tr>
<tr>
<td valign="top" align="left">Duration of antibiotic therapy (days) (25th&#x2013;75th interval)</td>
<td valign="top" align="center">51 (42&#x2013;66)</td>
<td valign="top" align="center">58 (43&#x2013;78)</td>
<td valign="top" align="center">0.053</td>
</tr>
<tr>
<td valign="top" align="left" colspan="4">Blood utilization</td>
</tr>
<tr>
<td valign="top" align="left">Erythrocyte concentrate (25th&#x2013;75th interval)</td>
<td valign="top" align="center">5 (2&#x2013;8)</td>
<td valign="top" align="center">5 (3&#x2013;9)</td>
<td valign="top" align="center">0.662</td>
</tr>
<tr>
<td valign="top" align="left">Thrombocyte concentrate (25th&#x2013;75th interval)</td>
<td valign="top" align="center">1 (0&#x2013;1)</td>
<td valign="top" align="center">0 (0&#x2013;1)</td>
<td valign="top" align="center">0.627</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn21"><p>Values are presented as median and interquartile range.</p></fn>
<fn id="table-fn22"><p>Continuous variables were compared using Mann&#x2013;Whitney <italic>U</italic> test.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>The administration of erythrocyte concentrate, and thrombocyte concentrate were similar among the study groups during the intraoperative period and throughout the entire postoperative hospital stay, encompassing stay at the intensive care unit, intermediate care unit (if applicable), and standard care unit (<xref ref-type="table" rid="T6">Table&#x00A0;6</xref>).</p>
</sec>
<sec id="s3h"><title>Causes of death</title>
<p>The causes of death were comparable among the study groups (<xref ref-type="table" rid="T7">Table&#x00A0;7</xref>).</p>
<table-wrap id="T7" position="float"><label>Table 7</label>
<caption><p>Causes of death.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Variables</th>
<th valign="top" align="center">Automated titanium fastener<break/><italic>N</italic>&#x2009;&#x003D;&#x2009;114<break/>(51.8&#x0025;)</th>
<th valign="top" align="center">Hand-tied knots<break/><italic>N</italic>&#x2009;&#x003D;&#x2009;106<break/>(48.2&#x0025;)</th>
<th valign="top" align="center"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Cardiac (&#x0025;)</td>
<td valign="top" align="center">10 (8.8)</td>
<td valign="top" align="center">10 (9.4)</td>
<td valign="top" align="center">0.864</td>
</tr>
<tr>
<td valign="top" align="left">Infection (&#x0025;)</td>
<td valign="top" align="center">7 (6.1)</td>
<td valign="top" align="center">11 (10.4)</td>
<td valign="top" align="center">0.252</td>
</tr>
<tr>
<td valign="top" align="left">Multi-organ failure (&#x0025;)</td>
<td valign="top" align="center">6 (5.3)</td>
<td valign="top" align="center">3 (2.8)</td>
<td valign="top" align="center">0.363</td>
</tr>
<tr>
<td valign="top" align="left">Neurological (&#x0025;)</td>
<td valign="top" align="center">3 (2.6)</td>
<td valign="top" align="center">4 (3.8)</td>
<td valign="top" align="center">0.630</td>
</tr>
<tr>
<td valign="top" align="left">Cancer (&#x0025;)</td>
<td valign="top" align="center">0 (0.0)</td>
<td valign="top" align="center">1 (0.9)</td>
<td valign="top" align="center">0.299</td>
</tr>
<tr>
<td valign="top" align="left">Other (&#x0025;)</td>
<td valign="top" align="center">2 (1.8)</td>
<td valign="top" align="center">1 (0.9)</td>
<td valign="top" align="center">0.604</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn23"><p>Values are presented as <italic>n</italic> (&#x0025;).</p></fn>
<fn id="table-fn24"><p>Categorical variables were compared using chi-square test.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><title>Discussion</title>
<p>The findings derived from the present study are (1): The suture-securing with automated titanium fastener was associated with a significantly lower risk of re-endocarditis during follow-up; (2) The automated titanium fastener group was not associated with an increased risk of stroke, all-cause mortality, or composite outcome during the follow-up; (3) The rate of re-endocarditis with an initial pathogen was significantly lower in the automated titanium fastener group.</p>
<p>To the best of our knowledge, this is the first study to examine the long-term outcomes based on the suture-securing technique used (automated titanium fastener vs. hand-tied knots) during prosthesis fixation in active IE, thereby highlighting its significance and novelty in clinical practice.</p>
<p>Nevertheless, in the elective clinical setting several studies reported the advantages of automated titanium fastener over hand-tied knots in reducing the CPB and cross-clamp time during minimally invasive valve surgery (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). In contrast, we found no differences in either CPB or cross-clamp duration between the study groups, which might be attributed to the variability of IE lesions and the resulting surgical complexity as well as concomitant procedures e.g., CABG surgery.</p>
<p>The automated titanium fastener is designed in a cylindrical shape, composed of surgical titanium. Indeed, a paucity of studies reported that surgical titanium might trigger thrombogenicity, when interfering with blood through the complex series of interconnected processes involving the adhesion and activation of both plasma proteins and platelets and subsequent activation of the intrinsic coagulation pathway (<xref ref-type="bibr" rid="B9">9</xref>&#x2013;<xref ref-type="bibr" rid="B12">12</xref>). Of concern, in the context of IE, thrombogenicity is even more pronounced due to the septic condition and ensuing hypercoagulability (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Interestingly, our analysis shows that the automated titanium fastener was not associated with an increased risk of stroke-onset (adjusted HR 0.54, 95&#x0025; CI 0.27&#x2013;1.08, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.082). We assume that the flat surface area of the crimped automated titanium fastener causes fewer hemodynamic alterations and therefore might not promote thrombogenicity. Similarly, in elective minimally invasive AVR surgery, Plestis et al. analyzed postoperative clinical outcomes based on the facilitating technologies used (automated titanium fastener and Custodiol solution vs. no-automated titanium fastener and no-Custodiol solution) and found no statistically significant difference in the incidence of stroke among study groups during the hospital stay (<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>The major finding of this study is that suture-securing with an automated titanium fastener is associated with a significantly lower risk of re-endocarditis during follow-up (adjusted sub-hazard ratio 0.33, 95&#x0025; CI 0.11&#x2013;0.99, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.048). This finding is of particular importance since it might affect surgeon preferences in decision-making towards suture-securing technique for prosthesis fixation in the setting of IE. At this point, no evidence is available addressing this topic. We believe that the flat, smooth surface of the crimped automated titanium fastener around the suture may act as a protective sheath, thus reducing bacterial adhesion. Literature suggests that bacterial adherence and growth are favored on braided sutures, especially on multiple hand-tied knots, thus enhancing the formation of a biofilm (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). The nature of biofilm formation facilitates bacterial resistance to antibiotic treatment (<xref ref-type="bibr" rid="B17">17</xref>). Also, the irregular topography of the multiple braided sutures increases the surface area available for bacterial attachment, subsequently increasing the risk of aggravating the infection (<xref ref-type="bibr" rid="B16">16</xref>&#x2013;<xref ref-type="bibr" rid="B18">18</xref>).</p>
<p>Furthermore, no-touch principle by using the automated titanium fastener device might be considered as a preferred practice, especially for this subset of patients. It is important to acknowledge that surgeons might inadvertently have contaminated surgical gloves while tying knots manually. Also, in the present analysis, the rate of re-endocarditis with the initial pathogen was significantly lower in the automated titanium fastener group (1.8&#x0025; vs. 9.4&#x0025;, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.012) (<xref ref-type="table" rid="T4">Table&#x00A0;4</xref>). Therefore, adhering strictly to the no-touch principle, and minimizing hand contact with the inflamed and infectious environment and with the newly implanted valve prosthesis might be beneficial.</p>
<p>Nonetheless, the cause of re-endocarditis is multifactorial (<xref ref-type="bibr" rid="B3">3</xref>). Therefore, this finding should be interpreted with caution.</p>
<sec id="s4a"><title>Study strengths and limitations</title>
<p>This study represents the first study to analyze long-term clinical outcomes based on the suturing technique used in prosthesis fixation for infective endocarditis, suggesting potentially lower risk of re-endocarditis when utilizing automated titanium fastener device.</p>
<p>Nonetheless, this study had some limitations: (1) It was retrospective single-center study with a relatively small study cohort; (2) Although the study groups were similar, they showed differences in terms of diabetes mellitus, preoperative atrial fibrillation, and CABG&#x2014;concomitant procedure. (3) The occurrence of re-endocarditis is attributed to multiple factors, irrespective of the suture-securing technique being used; (4) The use of automated titanium fastener was depending on surgeon&#x0027;s preference; (5) The current literature on this topic is sparse.</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusions"><title>Conclusion</title>
<p>Considering the results of the present analysis, the use of automated titanium fastener device seems to be safe in IE and might have potential advantages over the conventional technique of hand knot-tying. Analyses of larger cohorts are required.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability"><title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s11">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7" sec-type="ethics-statement"><title>Ethics statement</title>
<p>The studies involving humans were approved by Ethics Committee of the Medical University of Vienna (Ethical Number: 1872/2022; approval date 16.01.2023). The studies were conducted in accordance with the local legislation and institutional requirements. The ethics committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants&#x2019; legal guardians/next of kin because retrospective nature of the study.</p>
</sec>
<sec id="s8" sec-type="author-contributions"><title>Author contributions</title>
<p>AK: Conceptualization, Data curation, Investigation, Methodology, Writing &#x2013; original draft. PA: Conceptualization, Investigation, Writing &#x2013; original draft. HH: Conceptualization, Formal analysis, Methodology, Writing &#x2013; review &#x0026; editing. PW: Conceptualization, Investigation, Writing &#x2013; original draft. TP: Conceptualization, Investigation, Writing &#x2013; original draft. LA: Data curation, Investigation, Writing &#x2013; original draft. AK: Conceptualization, Writing &#x2013; review &#x0026; editing. ME: Investigation, Writing &#x2013; review &#x0026; editing. GL: Investigation, Resources, Supervision, Writing &#x2013; review &#x0026; editing. MA: Investigation, Methodology, Project administration, Resources, Supervision, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec id="s9" sec-type="funding-information"><title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<ack><title>Acknowledgments</title>
<p>The authors are thankful to our database administrator, Ms. Simon for the support in data acquisition for this study.</p>
</ack>
<sec id="s10" sec-type="COI-statement"><title>Conflict of interest</title>
<p>MA has received institutional research funding (Edwards, Abbott, Medtronic, LSI) and has served as a proctor/speaker/consultant (Edwards, Abbott, Medtronic, Zoll, Boston, Abbvie).</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s12" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material"><title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcvm.2024.1363336/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcvm.2024.1363336/full&#x0023;supplementary-material</ext-link></p>
<supplementary-material id="SD1" content-type="local-data">
<media mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="Table1.docx"/>
</supplementary-material>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Etiwy</surname><given-names>M</given-names></name><name><surname>Javadikasgari</surname><given-names>H</given-names></name><name><surname>Houghtaling</surname><given-names>P</given-names></name><name><surname>Gillinov</surname><given-names>M</given-names></name></person-group>. <article-title>Automated titanium fasteners versus hand-tied knots: a randomized controlled trial</article-title>. <source>Ann Thorac Surg</source>. (<year>2018</year>) <volume>106</volume>:<fpage>1160</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.athoracsur.2018.05.022</pub-id><pub-id pub-id-type="pmid">29883653</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sazzad</surname><given-names>F</given-names></name><name><surname>Xian</surname><given-names>OZ</given-names></name><name><surname>Ler</surname><given-names>A</given-names></name><name><surname>Guohao</surname><given-names>C</given-names></name><name><surname>Swee</surname><given-names>KG</given-names></name><name><surname>Kofidis</surname><given-names>T</given-names></name></person-group>. <article-title>Incidence of valvular regurgitation and leaflet perforation by using automated titanium fasteners (CORKNOT&#x00AE;) in heart valve repair or replacement: less usual than reported</article-title>. <source>J Cardiothorac Surg</source>. (<year>2021</year>) <volume>16</volume>:<fpage>163</fpage>. <pub-id pub-id-type="doi">10.1186/s13019-021-01512-z</pub-id><pub-id pub-id-type="pmid">34099017</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delgado</surname><given-names>V</given-names></name><name><surname>Ajmone Marsan</surname><given-names>N</given-names></name><name><surname>de Waha</surname><given-names>S</given-names></name><name><surname>Bonaros</surname><given-names>N</given-names></name><name><surname>Brida</surname><given-names>M</given-names></name><name><surname>Burri</surname><given-names>H</given-names></name><etal/></person-group> <article-title>2023 ESC guidelines for the management of endocarditis: developed by the task force on the management of endocarditis of the European Society of cardiology (ESC) endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM)</article-title>. <source>Eur Heart J</source>. (<year>2023</year>) <volume>44</volume>:<fpage>3948</fpage>&#x2013;<lpage>4042</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehad193</pub-id><pub-id pub-id-type="pmid">37622656</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vahanian</surname><given-names>A</given-names></name><name><surname>Beyersdorf</surname><given-names>F</given-names></name><name><surname>Praz</surname><given-names>F</given-names></name><name><surname>Milojevic</surname><given-names>M</given-names></name><name><surname>Baldus</surname><given-names>S</given-names></name><name><surname>Bauersachs</surname><given-names>J</given-names></name><etal/></person-group> <article-title>2021 ESC/EACTS guidelines for the management of valvular heart disease</article-title>. <source>Eur Heart J</source>. (<year>2022</year>) <volume>43</volume>:<fpage>561</fpage>&#x2013;<lpage>632</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehab395</pub-id><pub-id pub-id-type="pmid">34453165</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>JS</given-names></name><name><surname>Sexton</surname><given-names>DJ</given-names></name><name><surname>Mick</surname><given-names>N</given-names></name><name><surname>Nettles</surname><given-names>R</given-names></name><name><surname>Fowler</surname><given-names>VG</given-names><suffix>Jr</suffix></name><name><surname>Ryan</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Proposed modifications to the duke criteria for the diagnosis of infective endocarditis</article-title>. <source>Clin Infect Dis</source>. (<year>2000</year>) <volume>30</volume>:<fpage>633</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1086/313753</pub-id><pub-id pub-id-type="pmid">10770721</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leon</surname><given-names>MB</given-names></name><name><surname>Piazza</surname><given-names>N</given-names></name><name><surname>Nikolsky</surname><given-names>E</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name><name><surname>Cutlip</surname><given-names>DE</given-names></name><name><surname>Kappetein</surname><given-names>AP</given-names></name><etal/></person-group> <article-title>Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the valve academic research consortium</article-title>. <source>J Am Coll Cardiol</source>. (<year>2011</year>) <volume>57</volume>:<fpage>253</fpage>&#x2013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2010.12.005</pub-id><pub-id pub-id-type="pmid">21216553</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perin</surname><given-names>G</given-names></name><name><surname>Shaw</surname><given-names>M</given-names></name><name><surname>Pingle</surname><given-names>V</given-names></name><name><surname>Palmer</surname><given-names>K</given-names></name><name><surname>Al-Rawi</surname><given-names>O</given-names></name><name><surname>Ridgway</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Use of an automated knot fastener shortens operative times in minimally invasive mitral valve repair</article-title>. <source>Ann R Coll Surg Engl</source>. (<year>2019</year>) <volume>101</volume>:<fpage>522</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1308/rcsann.2019.0063</pub-id><pub-id pub-id-type="pmid">31155918</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grapow</surname><given-names>MT</given-names></name><name><surname>Mytsyk</surname><given-names>M</given-names></name><name><surname>Fassl</surname><given-names>J</given-names></name><name><surname>Etter</surname><given-names>P</given-names></name><name><surname>Matt</surname><given-names>P</given-names></name><name><surname>Eckstein</surname><given-names>FS</given-names></name><etal/></person-group> <article-title>Automated fastener versus manually tied knots in minimally invasive mitral valve repair: impact on operation time and short- term results</article-title>. <source>J Cardiothorac Surg</source>. (<year>2015</year>) <volume>10</volume>:<fpage>146</fpage>. <pub-id pub-id-type="doi">10.1186/s13019-015-0344-4</pub-id><pub-id pub-id-type="pmid">26530124</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gegenschatz-Schmid</surname><given-names>K</given-names></name><name><surname>Buzzi</surname><given-names>S</given-names></name><name><surname>Grossmann</surname><given-names>J</given-names></name><name><surname>Roschitzki</surname><given-names>B</given-names></name><name><surname>Urbanet</surname><given-names>R</given-names></name><name><surname>Heuberger</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Reduced thrombogenicity of surface-treated nitinol implants steered by altered protein adsorption</article-title>. <source>Acta Biomater</source>. (<year>2022</year>) <volume>137</volume>:<fpage>331</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2021.10.022</pub-id><pub-id pub-id-type="pmid">34673227</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Broberg</surname><given-names>M</given-names></name><name><surname>Eriksson</surname><given-names>C</given-names></name><name><surname>Nygren</surname><given-names>H</given-names></name></person-group>. <article-title>GpIIb/IIIa is the main receptor for initial platelet adhesion to glass and titanium surfaces in contact with whole blood</article-title>. <source>J Lab Clin Med</source>. (<year>2002</year>) <volume>139</volume>:<fpage>163</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1067/mlc.2002.121604</pub-id><pub-id pub-id-type="pmid">11944027</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>S&#x00E1;nchez</surname><given-names>J</given-names></name><name><surname>Lundquist</surname><given-names>PB</given-names></name><name><surname>Elgue</surname><given-names>G</given-names></name><name><surname>Larsson</surname><given-names>R</given-names></name><name><surname>Olsson</surname><given-names>P</given-names></name></person-group>. <article-title>Measuring the degree of plasma contact activation induced by artificial materials</article-title>. <source>Thromb Res</source>. (<year>2002</year>) <volume>105</volume>:<fpage>407</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/S0049-3848(02)00051-8</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dangas</surname><given-names>GD</given-names></name><name><surname>Weitz</surname><given-names>JI</given-names></name><name><surname>Giustino</surname><given-names>G</given-names></name><name><surname>Makkar</surname><given-names>R</given-names></name><name><surname>Mehran</surname><given-names>R</given-names></name></person-group>. <article-title>Prosthetic heart valve thrombosis</article-title>. <source>J Am Coll Cardiol</source>. (<year>2016</year>) <volume>68</volume>:<fpage>2670</fpage>&#x2013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2016.09.958</pub-id><pub-id pub-id-type="pmid">27978952</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simmons</surname><given-names>J</given-names></name><name><surname>Pittet</surname><given-names>JF</given-names></name></person-group>. <article-title>The coagulopathy of acute sepsis</article-title>. <source>Curr Opin Anaesthesiol</source>. (<year>2015</year>) <volume>28</volume>:<fpage>227</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1097/ACO.0000000000000163</pub-id><pub-id pub-id-type="pmid">25590467</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plestis</surname><given-names>K</given-names></name><name><surname>Orlov</surname><given-names>O</given-names></name><name><surname>Shah</surname><given-names>VN</given-names></name><name><surname>Wong</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Aharon</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Facilitating technologies in minimally invasive aortic valve replacement: a propensity score analysis</article-title>. <source>Interact Cardiovasc Thorac Surg</source>. (<year>2018</year>) <volume>27</volume>:<fpage>202</fpage>&#x2013;<lpage>07</lpage>. <pub-id pub-id-type="doi">10.1093/icvts/ivy026</pub-id><pub-id pub-id-type="pmid">29547910</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Henry-Stanley</surname><given-names>MJ</given-names></name><name><surname>Hess</surname><given-names>DJ</given-names></name><name><surname>Barnes</surname><given-names>AM</given-names></name><name><surname>Dunny</surname><given-names>GM</given-names></name><name><surname>Wells</surname><given-names>CL</given-names></name></person-group>. <article-title>Bacterial contamination of surgical suture resembles a biofilm</article-title>. <source>Surg Infect (Larchmt)</source>. (<year>2010</year>) <volume>11</volume>:<fpage>433</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1089/sur.2010.006</pub-id><pub-id pub-id-type="pmid">20673144</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>S</given-names></name><name><surname>Izhar</surname><given-names>M</given-names></name><name><surname>Mirelman</surname><given-names>D</given-names></name></person-group>. <article-title>Bacterial adherence to surgical sutures. A possible factor in suture induced infection</article-title>. <source>Ann Surg</source>. (<year>1981</year>) <volume>194</volume>:<fpage>35</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1097/00000658-198107000-00007</pub-id><pub-id pub-id-type="pmid">7018429</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dhom</surname><given-names>J</given-names></name><name><surname>Bloes</surname><given-names>DA</given-names></name><name><surname>Peschel</surname><given-names>A</given-names></name><name><surname>Hofmann</surname><given-names>UK</given-names></name></person-group>. <article-title>Bacterial adhesion to suture material in a contaminated wound model: comparison of monofilament, braided, and barbed sutures</article-title>. <source>J Orthop Res</source>. (<year>2017</year>) <volume>35</volume>:<fpage>925</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1002/jor.23305</pub-id><pub-id pub-id-type="pmid">27208547</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Bawazir</surname><given-names>M</given-names></name><name><surname>Dhall</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>HE</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Heo</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Implication of surface properties, bacterial motility, and hydrodynamic conditions on bacterial surface sensing and their initial adhesion</article-title>. <source>Front Bioeng Biotechnol</source>. (<year>2021</year>) <volume>9</volume>:<fpage>643722</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2021.643722</pub-id><pub-id pub-id-type="pmid">33644027</pub-id></citation></ref></ref-list>
</back>
</article>